$440.50 5.39 (1.24%)
17:49 EDT DXCM Stock Quote Delayed 30 Minutes
Previous Close $436.02
Market Cap 38.80B
PE Ratio -1,190.54
Volume (Avg. Vol.) 1.07M
Day's Range 428.50 - 445.52
52-Week Range 138.28 - 439.49
Dividend & Yield N/A (N/A)
DXCM Stock Predictions, Articles, and Dexcom News
- From InvestorPlace
- From the Web
While many companies were unable to avoid the wrath of the coronavirus pandemic, these three companies stood out as big winners.
Investors looking for internet of things stocks to buy should consider T, V, SWKS, DXCM and HON because all five offer great long-term growth potential as the industry develops.
The fear-mongering media had quite a few factors to scare investors with last Friday: the U.S.-China trade war, President Trump’s latest tweets, and the plummeting S&P 500. Underneath the big selloff, would you ever guess that plenty of stocks made new 52-week highs that very same day?
Put these fast-growing stocks on your radar, if not in your portfolio, as your best shot at overcoming the market's summertime blues.
The stock charts of UNH, TWTR and PM are poised to start the new trading week on the verge of big moves. Here are the levels to keep an eye on.
These Internet of Things stocks should be on your stocks to buy list as they have slipped under the radar and continue to present unique long-term opportunities in the IoT space.
Usually the steak is more important than the sizzle. These 10 stocks to buy may not be flashy, but they deserve a spot in your portfolio.
The trend of connected devices should provide plenty of opportunities for investors. The sector has nearly endless applications. So here are five companies to consider.
MedTech Stocks are hot, hot, hot. Here are five of the best to buy today for long-term growth.
Another dip in quarterly sales and profits confirms the worst fears for Fitbit stock holders as Fitbit Inc just can't find its lane.
Fitbit (FIT) is reportedly working on a version of Fibit for kids, but the device is still in the early stages of development.
The Fitbit investment in Sanos, a startup developing a coin-sized blood glucose monitor for diabetics, is proof that Fitbit has no intention of letting Apple dominate the health tracking market the same way it took over the smart watch market.
Fitbit stock hit an eight-month high before a recent pullback. But the "this time is different" story behind FIT stock isn't strong enough.
Fitbit stock got another boost on news it inked a deal with Dexcom to bring CGM data for diabetics to the Fitbit Ionic smartwatch.
The overall ratings of 7 Health Care Equipment & Supplies stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
This week, the ratings of 7 Health Care Equipment & Supplies stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
From Market News Video
Zuckerberg Tells Facebook Employees He's Not Going To Change Policies In Response To Advertiser Boycott
Navellier RatingsPowered by Portfolio Grader